Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04841772
Other study ID # 210203-B-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 8, 2021
Est. completion date December 1, 2022

Study information

Verified date March 2023
Source University of Exeter
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will allow researchers to explore how muscle responds to heavy exercise. The researchers will characterise rates of muscle protein breakdown and synthesis 24hours after heavy exercise with a post exercise protein polyphenol or placebo supplementation. This will inform strategies to help people recover from heavy exercise.


Description:

It is well known that resistance exercise increases rates of muscle protein synthesis and breakdown, with the rise in synthesis greater in magnitude and duration. The time course of rates of muscle protein synthesis increase dramatically 24-72h following eccentric exercise, even in a non-exercised control leg. This data is consistent with a much larger increase in muscle protein breakdown than previously thought. However, the response of muscle protein breakdown following damaging eccentric exercise, and its relationship with muscle protein synthesis, has not yet been elucidated. Moreover, it is unclear whether a protein and polyphenol nutritional intervention influence rates of muscle protein breakdown to accelerate recovery. This study will allow researchers to test the hypothesis that eccentric exercise increases rates of muscle protein breakdown independently of muscle contraction per se. If this hypothesis is supported, it will highlight that recovery strategies from muscle damage should also target supporting muscle protein breakdown.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date December 1, 2022
Est. primary completion date December 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Recreationally active - 18-40 years of age Exclusion Criteria: - Regular and structured involvement in resistance training - Inactive participants - Habitual dietary protein intake <0.8g/kg bw/day and >2.0g/kg bw/day - Regular use of nutritional supplements known to suppress inflammation or modulate protein metabolism Any diagnosed metabolic conditions (diabetes), cardiovascular disease or hypertension - Current musculoskeletal injury - Chronic use of anti-inflammatory medicines - Any known disorders in muscle metabolism - Individuals with an allergy to egg, fish, wheat or soy ingredients as the product is manufactured in a facility that contains these ingredients - Allergy to lidocaine - Having received or ingested a stable isotope tracer containing 15N in the past - A personal or family history of epilepsy, seizures or schizophrenia - Stomach bleeding or stomach ulcer - Kidney failure - Liver problems, such as fibrosis, cirrhosis or failure - Crohns disease or ulcerative colitis - Chickenpox or shingles - Pregnant or trying to get pregnant - Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension. - Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) - Recent (within the last 6 months) or current musculoskeletal injury (leg fracture)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Recover Vegan Protein Supplement
Post exercise protein supplement (26g pea protein)
Placebo
Post exercise placebo supplement (32g maltodextrin)

Locations

Country Name City State
United Kingdom University of Exeter Exeter Devon

Sponsors (2)

Lead Sponsor Collaborator
University of Exeter Beachbody

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle protein breakdown rate Muscle protein breakdown rate (FBR, measured in %/h) 24hours post eccentric exercise. 1hour
Secondary Muscle protein synthesis rate Muscle protein synthesis rate (FSR, measured in %/h) 24hours post eccentric exercise. 3hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1